BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell therapeutics for neurodegenerative diseases, this week presented new biomarker data from the Phase...
Company Provides Alzheimer’s Disease Patients Greater Access to Care through Administration of LEQEMBI In-home or On-site at its Infusion Centers
Soleo Health, an innovative leader and...
The Amvia Edge pacemaker platform introduces always-on, automatic MR detection algorithm to fully streamline MRI workflow.
BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval...
The US Food and Drug Administration (FDA) converted the approval process for Leqembi ( lecanemab-irmb), indicated for the treatment of adult patients with Alzheimer's...
Amneal Pharmaceuticals, Inc. announced the launch of its authorized generic for Xyrem® (Sodium Oxybate) oral solution CIII in the United States. Sodium Oxybate oral solution,...
